Vertex Pharmaceuticals (VRTX) EV to EBITDA (2009 - 2026)
Vertex Pharmaceuticals (VRTX) posted EV to EBITDA of 94.63 for Q2 2026, up 1.36% on a QoQ basis from 93.36 in Q1 2026, and up 1.12% year-over-year from 93.58 in Q2 2025.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) EV to EBITDA (2009 - 2026) Analysis & Trends
Vertex Pharmaceuticals has reported EV to EBITDA for 18 years, with the latest figure at 94.63 in Q2 2026.
- On a quarterly basis, EV to EBITDA rose 1.12% year-over-year to 94.63 in Q2 2026; TTM through Jun 2026 was 24.7, a 10.04% decrease from a year earlier, with the FY2025 full-year figure at 26.01, up 106.22% from the prior year.
- EV to EBITDA was 94.63 for Q2 2026 at Vertex Pharmaceuticals, up from 93.36 in the prior quarter.
- The five-year high for EV to EBITDA was 187.88 in Q1 2025, with the low at 32.76 in Q2 2024.
- Average EV to EBITDA over 5 years is 80.94, with a median of 87.92 recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: EV to EBITDA tumbled 142.3% in 2024, then soared 385.65% in 2025.
- Over 5 years, EV to EBITDA stood at 61.38 in 2022, then jumped by 54.31% to 94.72 in 2023, then advanced by 0.17% to 94.89 in 2024, then slipped by 5.14% to 90.01 in 2025, then rose by 5.13% to 94.63 in 2026.
- The last three EV to EBITDA figures came in at 94.63 (Q2 2026), 93.36 (Q1 2026), and 90.01 (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.01 Bn | 628.25 Bn | 17.26 Bn |
| 2 | AbbVie | 468.55 Bn | 462.03 Bn | 12.70 Bn |
| 3 | Merck | 365.49 Bn | 358.40 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.39 Bn | 265.10 Bn | 11.24 Bn |
| 5 | Astrazeneca | 253.18 Bn | 247.96 Bn | 12.86 Bn |
| 6 | Amgen | 219.53 Bn | 205.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.85 Bn | 184.59 Bn | 6.22 Bn |
| 8 | Pfizer | 160.56 Bn | 149.16 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 130.81 Bn | 122.96 Bn | 2.84 Bn |
| 10 | Bristol Myers Squibb | 124.95 Bn | 113.89 Bn | 9.25 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 94.63 |
| Mar 31, 2026 | 93.36 |
| Dec 31, 2025 | 90.01 |
| Sep 30, 2025 | 78.55 |
| Jun 30, 2025 | 93.58 |
| Mar 31, 2025 | 187.88 |
| Dec 31, 2024 | 94.89 |
| Sep 30, 2024 | 101.54 |
| Jun 30, 2024 | -32.76 |
| Mar 31, 2024 | 85.83 |
| Dec 31, 2023 | 94.72 |
| Sep 30, 2023 | 74.88 |
| Jun 30, 2023 | 77.44 |
| Mar 31, 2023 | 90.78 |
| Dec 31, 2022 | 61.38 |
| Sep 30, 2022 | 57.28 |
| Jun 30, 2022 | 56.85 |
| Mar 31, 2022 | 56.16 |
| Dec 31, 2021 | 55.10 |
| Sep 30, 2021 | 37.47 |
API Access
Vertex Pharmaceuticals EV to EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-ebitda", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();